Akari Therapeutics
AKTX | NASDAQ
$8.10
-$0.15 (-1.82%)
Nov 2, 2026, 10:33 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 13K | 13K | 13K | 13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | -13K | -13K | -13K | -13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -30.99M | -29.51M | -17.28M | -19.33M | -14.85M | -19.18M | -21.64M | -21.46M | -21.04M | -18.2M | -16.81M | -17.73M | -21.24M | -22.44M | -23.09M | -22.95M | -18.4M | -16.91M | -17.21M | -18.24M | -17.02M | -18.6M |
Interest Income | 993.99 | 993.99 | 993.99 | 1.99K | 4K | 6K | 8K | 7.01K | 20.01K | 47.01K | 75.01K | 75.02K | 59.04K | 33.99K | 8.35K | 12.31K | 13.67K | 11.23K | 10.6K | 11.94K | 16.7K | 16.34K |
Pretax Income | -32.82M | -29.91M | -18.3M | -16.86M | -12.27M | -17.93M | -19.79M | -20.16M | -20.13M | -16.58M | -10.01M | -9.32M | -9.89M | -11.57M | -17.75M | -20.09M | -18.1M | -16.76M | -17.42M | -18.45M | -16.08M | -19.17M |
Net Income | -30.96M | -28.05M | -17.3M | -15.77M | -12.27M | -17.93M | -19.79M | -20.16M | -20.13M | -16.58M | -10.01M | -9.32M | -9.89M | -11.57M | -17.75M | -20.09M | -18.1M | -16.76M | -17.42M | -18.45M | -16.08M | -19.17M |
Selling & General & Admin | 8.81M | 8.74M | 9.28M | 10.19M | 9.92M | 9.71M | 10.7M | 10.23M | 11.34M | 12.19M | 11.36M | 12.5M | 13.41M | 13.29M | 13.53M | 11.82M | 9.98M | 9.17M | 8.08M | 8.29M | 8.24M | 8.09M |
Research & Development | 4.87M | 3.46M | 2.82M | 2.98M | 2.87M | 5.52M | 6.98M | 10.82M | 10.36M | 8.57M | 8.02M | 6.39M | 10.14M | 11.47M | 11.88M | 15.35M | 11.48M | 10.81M | 12.2M | 13.31M | 12.15M | 12.99M |
Other Expenses | 17.31M | 17.31M | 5.18M | 6.16M | 2.06M | 3.95M | 3.95M | 398K | -677K | -2.57M | -2.57M | -1.16M | -2.32M | -2.32M | -2.32M | -4.23M | -3.07M | -3.07M | -3.07M | -3.37M | -3.37M | -2.47M |
Operating Expenses | 30.99M | 29.51M | 17.28M | 19.33M | 14.85M | 19.18M | 21.63M | 21.44M | 21.02M | 18.19M | 16.81M | 17.73M | 21.24M | 22.44M | 23.09M | 22.95M | 18.4M | 16.91M | 17.21M | 18.24M | 17.02M | 18.6M |
Interest Expense | 984.27K | 954.27K | 948.27K | 349.27K | 298K | 299K | 244K | 120K | 51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 3.69M | 3.69M | 3.69M | 3.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 30.99M | 29.51M | 17.28M | 19.33M | 14.85M | 19.18M | 21.64M | 21.46M | 21.04M | 18.2M | 16.81M | 17.73M | 21.24M | 22.44M | 23.09M | 22.95M | 18.4M | 16.91M | 17.21M | 18.24M | 17.02M | 18.6M |
Income Tax Expense | -1.86M | -1.86M | -1M | -1.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.79M | 21.04K | 21.04K | 16.33K | 15.74K | 13.65K | 9.7K | 6.1K | 4.71K | 3.36K | 2.2K | 2.53K | 2.53K | 1.89K | 1.71K | 1.71K | 1.48K | 1.34K | 1.19K | 1.16K | 961 | 961 |
Shares Outstanding (Diluted) | 1.79M | 21.04K | 21.04K | 16.33K | 15.74K | 13.65K | 9.7K | 6.1K | 4.71K | 3.36K | 2.2K | 2.53K | 2.53K | 1.89K | 1.71K | 1.71K | 1.48K | 1.34K | 1.19K | 1.16K | 961 | 961 |
EPS (Basic) | -1.6K | -1.45K | -1.03K | -1.18K | -1.26K | -2.74K | -4.13K | -5.62K | -6.28K | -6.26K | -4.07K | -4.21K | -5.09K | -7.34K | -12K | -14.4K | -13.6K | -14.4K | -16.8K | -22.4K | -20K | -24.8K |
EPS (Diluted) | -1.6K | -1.45K | -1.03K | -1.18K | -1.26K | -2.74K | -4.13K | -5.62K | -6.28K | -6.26K | -4.07K | -4.21K | -5.09K | -7.34K | -12K | -14.4K | -13.6K | -14.4K | -16.8K | -22.4K | -20K | -24.8K |
EBITDA | -31.84M | -28.96M | -17.35M | -16.51M | -11.97M | -17.63M | -19.53M | -20.02M | -20.07M | -16.56M | -10M | -9.31M | -9.89M | -11.57M | -17.74M | -20.09M | -18.09M | -16.76M | -17.13M | -18.24M | -17.03M | -17.7M |
EBIT | -31.84M | -28.96M | -17.35M | -16.51M | -11.97M | -17.63M | -19.55M | -20.04M | -20.08M | -16.58M | -10.01M | -9.32M | -9.89M | -11.57M | -17.75M | -20.09M | -18.1M | -16.76M | -17.13M | -18.24M | -17.04M | -17.7M |
Depreciation & Amortization | n/a | n/a | n/a | 1K | 1K | 1K | 14K | 14K | 15K | 16K | 4K | 4.03K | 4.05K | 3.99K | 4K | 3.98K | 3.99K | 4.1K | 4.13K | 4.12K | 4.07K | 6.06K |
Add to Watchlist
Select watchlists to add or remove AKTX